Literature DB >> 23001801

Cryptogenic organizing pneumonia.

Vincent Cottin1, Jean-François Cordier.   

Abstract

Organizing pneumonia (OP) is a pathological pattern defined by the characteristic presence of buds of granulation tissue within the lumen of distal pulmonary airspaces consisting of fibroblasts and myofibroblasts intermixed with loose connective matrix. This pattern is the hallmark of a clinical pathological entity, namely cryptogenic organizing pneumonia (COP) when no cause or etiologic context is found. The process of intraalveolar organization results from a sequence of alveolar injury, alveolar deposition of fibrin, and colonization of fibrin with proliferating fibroblasts. A tremendous challenge for research is represented by the analysis of features that differentiate the reversible process of OP from that of fibroblastic foci driving irreversible fibrosis in usual interstitial pneumonia because they may determine the different outcomes of COP and idiopathic pulmonary fibrosis (IPF), respectively. Three main imaging patterns of COP have been described: (1) multiple patchy alveolar opacities (typical pattern), (2) solitary focal nodule or mass (focal pattern), and (3) diffuse infiltrative opacities, although several other uncommon patterns have been reported, especially the reversed halo sign (atoll sign). Definitive diagnosis is based on (1) a suggestive clinical radiological presentation, (2) the demonstration of the characteristic pathological pattern at lung histopathology, and (3) exclusion of possible causes. Transbronchial biopsies or a transthoracic biopsy may also contribute to the pathological diagnosis. Rapid clinical and imaging improvement is obtained with corticosteroid therapy. Because of the risk of misdiagnosing alternative conditions that may mimic OP, only typical cases may be managed without histopathological confirmation, and patients should be followed with particular attention paid to any clue of alternate diagnosis, especially in case of incomplete response to treatment. Patients and clinicians must be aware of frequent relapses after stopping corticosteroid treatment. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001801     DOI: 10.1055/s-0032-1325157

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  33 in total

1.  Reversed halo sign in cryptogenic organising pneumonia.

Authors:  Jesper Rømhild Davidsen; Helle Dall Madsen; Christian B Laursen
Journal:  BMJ Case Rep       Date:  2016-02-08

2.  Cryptogenic organising pneumonia presenting with bilateral hilar and mediastinal lymphadenopathy.

Authors:  Hasan Kahraman; Mahmut Tokur; Hamide Sayar; Mehmet Fatih Inci
Journal:  BMJ Case Rep       Date:  2013-06-10

3.  Lesion with morphologic feature of organizing pneumonia (OP) in CT-guided lung biopsy samples for diagnosis of bronchiolitis obliterans organizing pneumonia (BOOP): a retrospective study of 134 cases in a single center.

Authors:  Liyun Miao; Yongsheng Wang; Yan Li; Jingjing Ding; Lulu Chen; Jinghong Dai; Hourong Cai; Yonglong Xiao; Min Cao; Mei Huang; Yuying Qiu; Fanqing Meng; Xiangshan Fan; Deping Zhang; Yong Song
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

4.  Clinicopathological findings of focal organizing pneumonia: a retrospective study of 37 cases.

Authors:  Zhen Huo; Ruie Feng; Xinlun Tian; Haibo Zhang; Li Huo; Hongrui Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

5.  Interstitial Lung Disease Associated with Connective Tissue Diseases.

Authors:  Ruben A Peredo; Vivek Mehta; Scott Beegle
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Organizing pneumonia and occupational and environmental risk factors: a case-control study.

Authors:  Stéphanie Jobard; Benjamin Chaigne; Sylvain Marchand-Adam; Gérard Lasfargues; Elisabeth Diot
Journal:  Int Arch Occup Environ Health       Date:  2017-08-01       Impact factor: 3.015

7.  Organizing pneumonia revisited: insights and uncertainties from a series of 67 patients.

Authors:  A L Vieira; A Vale; N Melo; P Caetano Mota; J M Jesus; R Cunha; S Guimarães; C Souto Moura; A Morais
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

8.  'Crazy-paving' pattern: an exceptional presentation of cryptogenic organising pneumonia associated with chronic obstructive pulmonary disease.

Authors:  Shekhar Kunal; Vikas Pilaniya; Sudhir Jain; Ashok Shah
Journal:  BMJ Case Rep       Date:  2016-05-06

Review 9.  Interstitial lung disease: the diagnostic role of bronchoscopy.

Authors:  Jad Kebbe; Tony Abdo
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

10.  Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.

Authors:  Alison Bamberg; Elizabeth F Redente; Steve D Groshong; Rubin M Tuder; Carlyne D Cool; Rebecca C Keith; Benjamin L Edelman; Bart P Black; Gregory P Cosgrove; Murry W Wynes; Douglas Curran-Everett; Stijn De Langhe; Luis A Ortiz; Andrew Thorburn; David W H Riches
Journal:  Am J Respir Crit Care Med       Date:  2018-10-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.